Barclays
DRIO icon

Barclays’s DarioHealth DRIO Stock Holding History

Barclays’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172 Buy
+26
New +$193 ﹤0.01% 5132
2025
Q2 		– Sell
-2
Closed -$21 – 5337
2025
Q1 		$21 Buy
+2
New +$28 ﹤0.01% 5169
2022
Q2 		– Sell
-109
Closed -$13K – 5079
2022
Q1 		$13K Buy
+109
New +$18K ﹤0.01% 4547

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Barclays's DRIO Position: Q2 2026 in Review

Barclays opened a new position in DarioHealth (DRIO) in Q2 2026: 26 shares worth $172. The stake represents ﹤0.01% of the portfolio and ranks #5132 among its holdings. This is a return to the name: Barclays previously reported a position in DRIO as recently as Q1 2025.

Barclays first reported a position in DRIO in Q1 2022 and has held it in 3 quarters since. The position peaked at $13K in Q1 2022. 21 funds tracked by Wall St. Rank hold DRIO as of Q2 2026.

  • Barclays held 26 shares of DarioHealth worth $172 as of Q2 2026.
  • DarioHealth was a new Barclays position in Q2 2026.
  • DarioHealth made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5132 holding.
  • Barclays first reported a position in DarioHealth in Q1 2022 and has held it in 3 quarters since.
  • Barclays's DarioHealth position peaked at $13K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.